Biopharma and Health Related News

AmpliPhi Biosciences Announces Pricing of $6.6 Million Underwritten Public Offering

SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE AMERICAN: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for patients with serious and life-threatening antibiotic-resistant bacterial infections, today announced the pricing of an underwritten public offering of 16,537,500 shares of [...]

Inovio’s Ebola Vaccine Provides 100% Protection And Elicits Long-Lasting Immune Responses in Preclinical Studies

Article in Journal of Infectious Diseases Supports Rationale For Inovio’s Ebola Vaccine Stockpile Program PLYMOUTH MEETING, Pa., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that its Ebola vaccine (INO-4212) provided 100% protection following a challenge [...]

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide. Canopy BiosciencesTM, LLC, an established provider of gene editing and personalized medicine technologies, today announced the introduction of a new catalog of over 2000 knockout cell lines and [...]

Meet Staph epidermidis, gatekeeper of healthy skin

This story is brought to you by Azitra, a preclinical stage biotechnology company combining the power of the microbiome with cutting-edge genetic engineering to treat skin disease. With all of the talk about CRISPR and genome editing these days, it [...]

Platelet BioGenesis and Scaled Biolabs to Collaborate To Optimize Platelet Production Platform

Companies to work together to de-risk manufacture of functional human platelets at scale Cambridge, Mass., and San Francisco – October 2 (Business Wire) – Platelet BioGenesis (PBG), the leader in the production of functional human platelets (PLTs+TM) from stem cells and [...]

Bristol-based company breaks records for a UK biodesign exit

Biodesign spinout company Ziylo has been acquired by global healthcare company Novo Nordisk in a deal that could exceed $800M. Ziylo was founded in 2014 by Professor Tony Davis, Dr Harry Destecroix and Tom Smart. Based on University of Bristol [...]